The impact of intracellular generation of nitric oxide on the radiation response of human tumor cells

Radiation Research

Volumn 171, Issue 5, 2009, Pages 572-580

  Singh, Simendra ^a,b   Cowen, Rachel L ^a   Chinje, Edwin C ^a,c   Stratford, Ian J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Morvus Technology Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; OXYGEN;

ARTICLE; CANCER RADIOTHERAPY; CELL HYPOXIA; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; OXYGEN TENSION; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; TUMOR CELL; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; RADIATION DOSE; TUMOR CELL LINE;

MAMMALIA;

CELL LINE, TUMOR; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; RADIATION TOLERANCE;

EID: 67650686824     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1640.1     Document Type: Article

References (56)

1. L. H. Gray, A. D. Conger, M. Ebert, S. Hornsey and O. C. Scott, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26, 638-648 (1953).
2. P. Howard-Flanders, Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180, 1191-1192 (1957).
3. P. Howard-Flanders and P. Jockey, Similarities in the effects of oxygen and nitric oxide on the rate of inactivation of vegetative bacteria by x-rays. Radiat. Res. 13, 466-478 (1960).
4. L. H. Gray, F. O. Green and C. A. Hawes, Effect of nitric oxide on the radiosensitivity of tumour cells. Nature 182, 952-953 (1958).
5. D. L. Dewey, Effect of oxygen and nitric oxide on the radio-sensitivity of human cells in tissue culture. Nature 186, 780-782 (1960).
6. P. T. Emmerson and P. Howard-Flanders, Preferential sensitization of anoxic bacteria to x-rays by organic nitroxide-free radicals. Radiat. Res. 26, 54-62 (1965).
7. B. C. Cooke, E. M. Fielden and M. Johnson, Polyfunctional radio-sensitizers. I. Effects of a nitroxyl biradical on the survival of mammalian cells in vitro. Radiat. Res. 65, 152-162 (1976).
8. B. C. Millar, T. C. Jenkins and E. M. Fielden, Polyfunctional radio-sensitizers. V. Sensitization of hypoxic Chinese hamster cells, V.79-753B, in vitro by a series of bifunctional nitroxyl compounds. Radiat. Res. 90, 271-283 (1982).
9. N. M. Blackett, W. E. Wooliscroft, E. M. Fielden and S. C. Lillicrap, Radiation modifying effect of the free radical norpseudopelletierene-N-oxyl on normal bone marrow stem cells in vitro and in vivo. Radiat. Res. 58, 361-372 (1974).
10. R. P. Hill, E. M. Fielden, S. C. Lillicrap and J. A. Stanley, Letter: Studies of the radiosensitizing action in vivo of 2,2,6,6, tetramethyl-4-piperidinol-N-oxyl (TMPN). Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 27, 499-501 (1975).
11. W. R. Hendric, J. A. Thomas, A. Mathew and J. D. Zimbrick, 2,2,5,5-Tetramethyl-1-pyrrolidinyl-oxy-3-carboxylic acid (PCA) as a potential radiosensitizer in vivo. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 40, 451-454 (1981).
12. E. Culotta and D. E. Koshland, Jr., NO news is good news. Science 258, 1862-1865 (1992).
13. J. B. Mitchell, D. A. Wink, W. DeGraff, J. Gamson, L. K. Keefer and M. C. Krishna, Hypoxic mammalian cell radiosensitisation by nitric oxide. Cancer Res. 53, 5845-5848 (1993).
14. R. J. Griffin, C. M. Makepeace, W. J. Hur and C. W. Song, Radio-sensitisation of hypoxic tumor cells in vitro by nitric oxide. Int. J. Radiat. Oncol. Biol. Phys. 36, 377-383 (1996).
15. P. J. Wood, J. M. Sansom, I. J. Stratford, G. E. Adams, C. Szabo, C. Thiemermann and J. R. Vane, Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1. Br. J. Cancer 74 (Suppl. XXVII), S177-S180 (1996).
16. V. N. Verovski, D. L. Van den Berge, G. A. Soete, B. L. Bols and G. A. Storme, Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br. J. Cancer 74, 1734-1742 (1996).
17. J. B. Mitchell, J. A. Cook, M. C. Krishna, W. DeGraff, J. Gamson, F. Fisher, D. Christodoulou and D. A. Wink, Radiation sensitisation by nitric oxide releasing agents. Br. J. Cancer 74 (Suppl. XXVII), S181-S184 (1996).
18. B. F. Jordan, N. Beghein, M. Aubry, V. Grégoire and B. Gallez, Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSaII murine tumors. Int. J. Cancer 103, 138-141 (2003).
19. L. L. Thomsen and D. W. Milo, Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev. 17, 107-118 (1998).
20. D. Fukumura and R. K. Jain, Role of nitric oxide in angiogenesis and microcirculation in tumours. Cancer Metastasis Rev. 17, 77-89 (1998).
21. M. Y. Janssens, D. L. Van den Berge, V. N. Verovski, C. Monsaert and G. A. Storme, Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitisation of hypoxic EMT-6 tumor cells. Cancer Res. 58, 5646-5648 (1998).
22. D. L. Van den Berge, M. De Ridder, V. N. Verovski, M. Y. Janssens, C. Monsaert and G. A. Storme, Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase. Br. J. Cancer 84, 1122-1125 (2001).
23. B. G. Wouters and J. M. Brown, Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat. Res. 147, 541-550 (1997).
24. E. C. Chinje, R. L. Cowen, J. Feng, S. P. Sharma, N. S. Wind, A. L. Harris and I. J. Stratford, Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitro. Mol. Pharmacol. 63, 1248-1255 (2003).
25. S. Kwon and S. C. George, Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide 3, 348-357 (1999).
26. S. Kwon, R. L. Newcomb and S. C. George, Mechanisms of synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells. Nitric Oxide Biol. Chem. 5, 534-546 (2001).
27. Z. Guo, L. Shao, Q. Du, K. S. Park and D. A. Geller, Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. FASEB J. 21, 535-542 (2007).
28. C. C. McCormick, W. P. Li and M. Calero, Oxygen tension limits nitric oxide synthesis by activated macrophages. Biochem. J. 350, 709-716 (2000).
29. D. S. Tendler, C. Bao, T Wang, E. L. Huang, E. A. Ratovitski, D. A. Pardoll and C. J. Lowenstein, Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumour apoptosis. Cancer Res. 61, 3682-3688 (2001).
30. G. D'Amico, F. Lam, T. Hagen and S. Moncada, Inhibition of cellular respiration by endogenously produced carbon monoxide. J. Cell Sci. 119, 2291-2298 (2006).
31. E. C. Chinje, K. J. Williams, B. A. Telfer, P. J. Wood, A. J. van der Kogel and I. J. Stratford, 17β-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on tumour growth and radiation response. Br. J. Cancer 86, 136-142 (2002).
32. P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson and D. C. Klenk, Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85 (1985).
33. P. Eyer and D. Podhradsky, Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal. Biochem. 153, 57-66 (1986).
34. B. C. Millar, E. M. Fielden and J. J. Steele, Effect of oxygen-radio-sensitizer mixtures on the radiation response of Chinese hamster cells, line V.79-753B, in vitro. I. Survival response. Radiat. Res. 82, 478-486 (1980).
35. J. A. Cook, M. C. Krishna, R. Pacelli, W DeGraff, J. Liebmann, J. B. Mitchell, A. Russo and D. A. Wink, Nitric oxide enhancement of melphalan-induced cytotoxicity. Br. J. Cancer 76, 325-334 (1997).
36. E. P. Clark, E. R. Epp, J. E. Biaglow, M. Morse-Gaudio and E. Zach-go, Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sul-foximine. Radiat. Res. 98, 370-380 (1984).
37. R. J. Hodgkiss and R. W Middleton, Enhancement of misonidazole radiosensitization by an inhibitor of glutathione biosynthesis. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 43, 179-183 (1983).
38. P. Wardman, K. Rothkamm, L. K. Folkes, M. Woodcock and P. J. Johnston, Radiosensitization by nitric oxide at low radiation doses. Radiat. Res. 167, 475-484 (2007).
39. P. Vaupel, K Schlenger, C. Knoop and M. Hockel, Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
40. M. Höckel, K Schlenger, C. Knoop and P. Vaupel, Oxygenation of human tumours evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51, 6098-6102 (1991).
41. D. M. Brizel, G. S. Sibley, L. R. Prosnitz, R. L. Scher and M. W Dewhirst, Tumour hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289 (1997).
42. S. Kashiwagi, Y. Izumi, T. Gohongi, Z. N. Demou, L. Xu, P. L. Huang, D. G. Buerk, L. L. Munn, R. K. Jain and D. Fukumura, NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 115, 1816-1827 (2005).
43. L. L. Thomsen, D. W. Miles, L. Happerfield, L. G. Bobrow, R. G. Knowles and S. Moncada, Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72, 41-44 (1995).
44. L. L. Thomsen, F. G. Lawton, R. G. Knowles, J. E. Beesley, V. Riveros-Moreno and S. Moncada, Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54, 1352-1354 (1994).
45. S. Ambs, W. G. Merriam, W. P. Bennett, E. Felley-Bosco, M. O. Ogunfusika, S. M. Oser, S. Klein, P. G. Shields, T. R. Billiar and C. C. Harris, Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58, 334-341 (1998).
46. A. Hajri, E. Metzgir, F. Vallat, S. Coffy, E. Flatter, S. Evrard, J. Marescaux and M. A. Aprahamian, Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro. Br. J. Cancer 78, 841-849 (1998).
47. D. C. Jenkins, I. G. Charles, L. L. Thomsen, D. W. Moss, L. S. Holmes, S. A. Baylis, P. Rhodes, K. Westmore and S. Moncada, Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92, 4392-4396 (1995).
48. Z. Wang, T. Cook, S. Alber, K. Liu, I. Kovesdi, S. K. Watkins, Y. Vodovotz, T. R. Billiar and D. Blumberg, Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res. 64, 1386-1395 (2004).
49. B. F. Jordan, V. Grégoire, R. J. Demeure, P. Sonveaux, O. Feron, J. O'Hara, V. P. Vanhulle, N. Delzenne and B. Gallez, Insulin increases the sensitivity of tumors to irradiation: Involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res. 62, 3555-3561 (2002).
50. T. Klotz, W. Bloch, C. Volberg, U. Engelmann and K. Addicks, Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82, 1897-1903 (2000).
51. A. Jayasurya, S. T. Dheen, W. M. Yap, N. G. Tan, Y. L. Ng and B. H. Bay, Inducible nitric oxide synthase and bcl-2 expression in naso-pharyngeal cancer: correlation with outcome of patients after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56, 837-845 (2003).
52. J. X. Yu, L. Cui, Q. Y. Zhang, H. Chen, P. Ji, H. J. Wei and H. Y. Ma, Expression of NOS and HIF-1 alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J. Gastroenterol. 12, 4660-4664 (2006).
53. E. Jablońska, W. Puzewska, M. Marcińczyk, Z. Grabowska and J. Jabloski, iNOS expression and NO production by neutrophils in cancer patients. Arch. Immunol. Ther. Exp. 53, 175-179 (2005).
54. K. Yamaguchi, H. Saito, S. Oro, S. Tatebe, M. Ikeguchi and S. Tsu-jitani, Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68, 471-478 (2005).
55. C. Menon, T. W. Bauer, S. T. Kelley, D. J. Raz, J. I. Bleier, K. Patel, K. Steele, I. Prabakaran, A. Shifrin and D. L. Fraker, Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by mac-rophage-derived nitric oxide burst and permanent blood flow shutdown. Int. J. Cancer 123, 464-475 (2008).
56. H. O. McCarthy, J. Worthington, E. Barrett, E. Cosimo, M. Boyd, R. J. Mairs, C. Ward, S. R. McKeown, D. G. Hirst and T. Robson, p21 (WAF1)-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizers tumours to fractionated radio-therapy. Gene Ther. 14, 246-255 (2007).